NALINI MORRIS: Open Payments
NPI 1700904083 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,038 in 128 payments from 14 companies in 2025. Trend: 2023 $1,334 · 2024 $1,491 · 2025 $2,038
Food & beverage: $2,038
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $439 |
| Neurocrine BioSciences, Inc. | 13 | $342 |
| ABBVIE INC. | 33 | $301 |
| E.R. Squibb & Sons, L.L.C. | 18 | $245 |
| Teva Pharmaceuticals USA, Inc. | 16 | $190 |
| Otsuka America Pharmaceutical, Inc. | 7 | $135 |
| Janssen Pharmaceuticals, Inc | 4 | $71 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
| Alkermes, Inc. | 4 | $64 |
| Lundbeck LLC | 3 | $62 |
Products named: CAPLYTA, INGREZZA, VRAYLAR, COBENFY, AUSTEDO XR, REXULTI, ABILIFY ASIMTUFII, HETLIOZ.
Industry payments across OH — which companies pay providers there.
